Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc (MRKR) Financials

MRKR Marker Therapeutics Inc

3.49

0.30 (9.40%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-33.709	-167.651	-439.54	-39.498	-62.422	-73.633	-58.369	-31.958
Return on Equity (%)	32.356	-223.143	-469.715	-41.436	-80.374	-117.422	-94.142	-48.951
Return on Invested Capital (%)	111.921	-236.981	-470.395	-43.565	-80.878	-110.69	-94.189	-86.682
Operating Margin (%)	N/A	N/A	-71824.272	-10060.094	-6146.895	-3371.9	-332.087	-424.101
Net Profit Margin (%)	N/A	N/A	-71824.272	-10060.094	-6146.895	-3371.9	-332.087	-248.777
Book Value Per Share	0.734	0.345	1.307	0.965	0.539	0.529	0.233	1.581
Earnings Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-0.927
Cash Per Share	0.932	0.484	1.36	0.961	0.421	0.51	0.14	1.7
Working Capital Per Share	0.734	0.345	1.304	0.952	0.355	0.398	0.105	1.581
Operating Profit Per Share	N/A	N/A	0.005	0.005	0.009	0.015	0.107	0.372
EBIT Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-1.58
EBITDA Per Share	-0.292	-1.036	-3.259	-0.469	-0.566	-0.504	-0.356	-1.58
Free Cash Flow Per Share	-0.292	-1.036	-3.256	-0.463	-0.37	-0.492	-0.331	-0.927

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	8.42M	10.6M	45.4M	45.7M	50.7M	83.1M	84M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	83.6M	84M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-104.943	N/A	N/A	N/A	-192.363	N/A
Net Profit Margin (%)	N/A	N/A	-104.943	N/A	N/A	N/A	-192.363	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	28.46M
Price to Earnings Ratio	-3.78
Price to Sales Ratio	9.4
Price to Cash Ratio	2.06
Price to Book Ratio	2.22
Dividend Yield	-

Share Statistics

Shares Outstanding	8.92M
Average Volume (1 week)	35.83k
Average Volume (1 Month)	30.55k
52 Week Change	27.37%
52 Week High	6.1568
52 Week Low	2.4377

More Ratios Coming Soon!

Marker Therapeutics

Ubs Bbg Jt 1-3 Ucits Etf...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions